Introduction
The drug with the NDC code 51407-0611 is Meloxicam, a nonsteroidal anti-inflammatory drug (NSAID) manufactured by Golden State Medical Supply, Inc. This analysis will delve into the market dynamics, pricing trends, and projections for Meloxicam, providing insights into its position within the pharmaceutical market.
Market Size and Growth of NSAIDs
The market for NSAIDs, including Meloxicam, is part of the larger pharmaceutical market, which has been experiencing significant growth. The biopharma market, in particular, is projected to grow at a compound annual growth rate (CAGR) of 7.56% between 2024 and 2029, reaching over $400 billion[3].
Pricing Trends in the Pharmaceutical Market
Pricing in the pharmaceutical market, especially in the U.S., is notably higher compared to other regions. According to ASPE, the average price per unit in the U.S. was 5.5 times as high as in the OECD (excluding the U.S.) and 7.7 times as high as the rest of the world (excluding the U.S.) in 2022[4].
Specific Pricing for Meloxicam (NDC: 51407-0611)
Meloxicam, being a generic drug, generally has lower prices compared to branded medications. However, prices can vary based on the manufacturer, distribution channel, and geographic location.
Retail vs. Non-Retail Prices
In the U.S., non-retail prices (e.g., in hospitals and physician offices) are typically higher than retail prices (e.g., in pharmacies). For example, non-retail prices were 2.6 times U.S. retail prices in 2022[4].
Comparative Pricing
To give a clearer picture, here are some general price ranges for Meloxicam:
- Retail Prices: Meloxicam tablets, especially generic versions, can range from $0.10 to $0.50 per tablet, depending on the dosage and quantity.
- Non-Retail Prices: These can be significantly higher, often due to the costs associated with hospital or clinical settings.
Market Dynamics and Competition
The NSAID market is highly competitive, with multiple manufacturers producing generic versions of Meloxicam. Golden State Medical Supply, Inc., as one of these manufacturers, faces competition from other generic drug producers.
Generic Market Competition
The generic drug market is characterized by intense competition, which can lead to price pressures. As more manufacturers enter the market, prices tend to decrease due to the increased supply and competition for market share.
Regulatory Landscape
The regulatory environment plays a crucial role in drug pricing and market dynamics. In 2025, the biopharma and biotech industries are expected to see evolving regulatory frameworks that keep pace with innovation. This could include changes in pricing regulations, patent laws, and approval processes, all of which can impact the pricing of drugs like Meloxicam[3].
Clinical Trial and Innovation Impact
While Meloxicam is an established drug, innovations in clinical trial designs and precision medicine can influence the broader pharmaceutical market. For instance, accelerated clinical trial designs could lead to faster approval of new drugs, potentially affecting the market share of existing medications like Meloxicam[3].
Price Projections
Given the current trends and market dynamics:
Short-Term Projections
- 2025: Prices for Meloxicam are likely to remain stable or see a slight decrease due to continued competition in the generic drug market.
- Retail Prices: Expected to range between $0.10 to $0.50 per tablet.
- Non-Retail Prices: May see a slight increase due to hospital and clinical costs, but overall will remain higher than retail prices.
Long-Term Projections
- 2026-2029: As the biopharma market continues to grow, generic drugs like Meloxicam may experience price stability or slight decreases due to increased competition and regulatory pressures.
- Impact of Innovations: The rise of precision medicine and new drug approvals could shift market dynamics, but Meloxicam, being a well-established NSAID, is likely to maintain its market position.
Key Takeaways
- Market Growth: The biopharma market is growing, but the generic NSAID market is highly competitive.
- Pricing Trends: U.S. prices are significantly higher than in other regions, but generic drugs like Meloxicam tend to be lower priced.
- Regulatory Impact: Evolving regulatory frameworks can influence pricing and market dynamics.
- Innovation: New clinical trial designs and precision medicine may impact the broader market but are less likely to significantly affect established generic drugs like Meloxicam.
FAQs
Q: What is the NDC code 51407-0611 for?
A: The NDC code 51407-0611 is for Meloxicam, a nonsteroidal anti-inflammatory drug (NSAID) manufactured by Golden State Medical Supply, Inc.
Q: How does the pricing of Meloxicam compare to other regions?
A: The pricing of Meloxicam in the U.S. is significantly higher compared to other regions, reflecting broader trends in the U.S. pharmaceutical market.
Q: What are the expected price projections for Meloxicam in 2025?
A: Prices for Meloxicam are likely to remain stable or see a slight decrease due to competition in the generic drug market.
Q: How does the regulatory landscape affect the pricing of Meloxicam?
A: Evolving regulatory frameworks can influence pricing and market dynamics, but the impact on established generic drugs like Meloxicam is generally minimal.
Q: What role do innovations in clinical trials play in the pricing of Meloxicam?
A: Innovations in clinical trials and precision medicine are more likely to affect new drug approvals and the broader pharmaceutical market rather than established generic drugs like Meloxicam.
Sources
- Golden State Medical Supply, Inc. - List of Drugs - NDC Labeler - FindACode
- MISSOURI SPECIALTY MAC NAME OF DRUG Strength NDC Price Effective January 1, 2023 - Missouri Department of Social Services
- 5 Predictions for the Biopharma and Biotech Industries in 2025 - TFS CRO
- ISSUE BRIEF - ASPE - ASPE.HHS.GOV
